Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6488934rdf:typepubmed:Citationlld:pubmed
pubmed-article:6488934lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:6488934lifeskim:mentionsumls-concept:C0001675lld:lifeskim
pubmed-article:6488934lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:6488934lifeskim:mentionsumls-concept:C0041041lld:lifeskim
pubmed-article:6488934lifeskim:mentionsumls-concept:C1705241lld:lifeskim
pubmed-article:6488934lifeskim:mentionsumls-concept:C1705242lld:lifeskim
pubmed-article:6488934pubmed:issue5lld:pubmed
pubmed-article:6488934pubmed:dateCreated1984-12-12lld:pubmed
pubmed-article:6488934pubmed:abstractTextWe used a new micromethod, an application of a previously published high-performance liquid chromatography assay, to investigate trimethoprim (TMP) pharmacokinetics in children. The subjects were 5 girls who were treated for urinary tract infection with a TMP suspension, 6 mg/kg/day, twice daily for 10 days. Elimination studies were done after the last dose. The girls were 1.08-9.71 years old. 3 healthy adult males, aged 26.35-37.31 served as controls. The half-life (t 1/2) of TMP in the children was 3.0-5.5 versus 9.3-13.6 h in the adults. The volume of distribution (Vd) was 0.7-1.1 1/kg in the children and 0.5-0.9 1/kg in the adults. Plasma clearance (Clp) was 2.1-2.8 ml/min/kg for the children. The adults had a smaller Clp of 0.4-1.2 ml/min/kg. From this and previous studies we conclude that the t 1/2 of TMP is much shorter in children than in adults.lld:pubmed
pubmed-article:6488934pubmed:languageenglld:pubmed
pubmed-article:6488934pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6488934pubmed:citationSubsetIMlld:pubmed
pubmed-article:6488934pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6488934pubmed:statusMEDLINElld:pubmed
pubmed-article:6488934pubmed:issn0009-3157lld:pubmed
pubmed-article:6488934pubmed:authorpubmed-author:ArjomaaPPlld:pubmed
pubmed-article:6488934pubmed:authorpubmed-author:HoppuKKlld:pubmed
pubmed-article:6488934pubmed:issnTypePrintlld:pubmed
pubmed-article:6488934pubmed:volume30lld:pubmed
pubmed-article:6488934pubmed:ownerNLMlld:pubmed
pubmed-article:6488934pubmed:authorsCompleteYlld:pubmed
pubmed-article:6488934pubmed:pagination283-7lld:pubmed
pubmed-article:6488934pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:6488934pubmed:meshHeadingpubmed-meshheading:6488934-...lld:pubmed
pubmed-article:6488934pubmed:meshHeadingpubmed-meshheading:6488934-...lld:pubmed
pubmed-article:6488934pubmed:meshHeadingpubmed-meshheading:6488934-...lld:pubmed
pubmed-article:6488934pubmed:meshHeadingpubmed-meshheading:6488934-...lld:pubmed
pubmed-article:6488934pubmed:meshHeadingpubmed-meshheading:6488934-...lld:pubmed
pubmed-article:6488934pubmed:meshHeadingpubmed-meshheading:6488934-...lld:pubmed
pubmed-article:6488934pubmed:meshHeadingpubmed-meshheading:6488934-...lld:pubmed
pubmed-article:6488934pubmed:meshHeadingpubmed-meshheading:6488934-...lld:pubmed
pubmed-article:6488934pubmed:meshHeadingpubmed-meshheading:6488934-...lld:pubmed
pubmed-article:6488934pubmed:meshHeadingpubmed-meshheading:6488934-...lld:pubmed
pubmed-article:6488934pubmed:meshHeadingpubmed-meshheading:6488934-...lld:pubmed
pubmed-article:6488934pubmed:meshHeadingpubmed-meshheading:6488934-...lld:pubmed
pubmed-article:6488934pubmed:meshHeadingpubmed-meshheading:6488934-...lld:pubmed
pubmed-article:6488934pubmed:year1984lld:pubmed
pubmed-article:6488934pubmed:articleTitleDifference in trimethoprim pharmacokinetics between children and adults.lld:pubmed
pubmed-article:6488934pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6488934pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6488934pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed